Skip to content
GenoLensGenoLens

AGL

Chr 1p21.2

amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase

Aliases:
GDE
MANE:
ENST00000361915.8

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Acute rhabdomyolysis

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Glycogen storage disease

    BIALLELIC, autosomal or pseudoautosomal
  • Ketotic hypoglycaemia

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Rhabdomyolysis and metabolic muscle disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal

+7 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • glycogen storage disease III

    0.83
  • disorder of glycogen metabolism

    0.77
  • Glycogen storage disease due to glycogenin deficiency

    0.61
  • hereditary disease

    0.51
  • Acute rhabdomyolysis

    0.46
  • Abnormality of metabolism/homeostasis

    0.34
  • response to xenobiotic stimulus

    0.29
  • exfoliative dermatitis

    0.26
  • ileostomy

    0.26
  • Meniere disease

    0.16

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Glycogen debranching enzyme

Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-glucosidase in glycogen degradation

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.